Delivery Order SPE2DB22D3301-SPE2DB24FZ0VE
Award Date
7/17/24
Potential Completion Date
7/18/24
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $10,681.42 firm-fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a medical product, with an ultimate completion date of June 12, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which provides a comprehensive global pharmaceutical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,877.84 firm fixed-price contract is for the procurement of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty pharmaceutical medication. The contract has an ultimate completion date of January 3, 2025. This delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the...
This is a $10,927.95 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML medication. It has an ultimate completion date of May 16, 2025 and was awarded on May 15, 2025. The contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp holds a larger $999,999,999.00...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The award is for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML and has a ceiling value of $6,787.97. The delivery order was issued under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty pharmaceutical product, with a ceiling value of $2,877.84 and a period of performance through April 29, 2025. The award is not associated with a set-aside program and represents an open competition. AmerisourceBergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $46,649.47 firm-fixed-price delivery order is for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty medication. The contract has an ultimate completion date of October 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order awarded to Amerisourcebergen Drug Corp (DUNS: TGxsdkVQRGhOYUpNR001SFhYREdNdz09) by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a pharmaceutical product. The contract is a firm fixed-price, indefinite-delivery contract with a ceiling value of $10,523.52 and a completion date of September 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
This is a $4,316.76 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML medication. The order has an ultimate completion date of January 9, 2025. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a medication, with a ceiling value of $25,292.98. The contract is a firm fixed price delivery order, with an ultimate completion date of June 26, 2025. The contract is not set aside and is open to competition. AmerisourceBergen Drug Corp holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a prescription medication. The $13,785.98 firm-fixed-price contract has an ultimate completion date of August 8, 2024. Amerisourcebergen holds several indefinite delivery contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000, respectively, for delivering a wide...